![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Acer Therapeutics Com USD0.01 | NASDAQ:OPXA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.9699 | 0.95 | 1.00 | 0 | 01:00:00 |
Acer
Therapeutics Inc.
|
(Name of
Issuer)
|
Common Stock, $0.01
par value
|
(Title of Class of Securities)
|
00444P108
|
(CUSIP
Number)
|
Chris
Schelling
Acer
Therapeutics Inc.
222
Third Street
Suite
#2240
Cambridge,
MA 02142
(844)
902-6100
With a
copy to:
David
R. Pierson, Esq.
Daniel
S. Clevenger, Esq.
Foley
Hoag LLP
155
Seaport Blvd.
Boston,
MA 02210
617-832-1000
|
(Name, address and telephone number of
person
authorized to receive notices and
communications)
|
September 19,
2017
|
(Date of event which requires filing of this
statement)
|
CUSIP No.
00444P108
|
SCHEDULE
13D
|
Page 2 of 6
Pages
|
1
|
NAME OF REPORTING
PERSONS
Chris
Schelling
|
|||
2
|
CHECK THE
APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
☐
(b)
☐
|
|||
3
|
SEC USE
ONLY
|
|||
4
|
SOURCE OF
FUNDS
OO
|
|||
5
|
CHECK BOX IF
DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM
2(d) or 2(e) ☐
|
|||
6
|
CITIZENSHIP OR
PLACE OF ORGANIZATION
United States
|
|||
NUMBER
OF
|
7
|
SOLE VOTING
POWER
|
1,750,000
|
|
SHARES
BENEFICIALLY
|
8
|
SHARED VOTING
POWER
|
0
|
|
OWNED
BY
EACH
|
9
|
SOLE DISPOSITIVE
POWER
|
1,750,000
|
|
REPORTING
PERSON
WITH
|
10
|
SHARED DISPOSITIVE
POWER
|
0
|
|
11
|
AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,750,000
|
|||
12
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN
SHARES ☐
|
|||
13
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (11)
27.1%
|
|||
14
|
TYPE OF REPORTING
PERSON
IN
|
CUSIP
No.
00444P108
|
SCHEDULE
13D
|
Page 3 of 6
Pages
|
CUSIP
No.
00444P108
|
SCHEDULE
13D
|
Page 4 of 6
Pages
|
CUSIP
No.
00444P108
|
SCHEDULE
13D
|
Page 5 of 6
Pages
|
|
|
|
|
|
|
|
|
Dated: September
29, 2017
|
By:
|
/s/ Chris Schelling
|
|
|
|
Chris Schelling
|
|
|
|
|
|
1 Year Acer Therapeutics Com USD0.01 Chart |
1 Month Acer Therapeutics Com USD0.01 Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions